Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.


We analyzed the correlation between well-established biological parameters of prognostic relevance in B-cell chronic lymphocytic leukemia (CLL) [i.e. mutational status of the immunoglobulin heavy chain variable region (IgVH), ZAP-70 and CD38 expression] and serum levels of B cell-activating factor (BAFF of the TNF family) by evaluating the impact of these… (More)
DOI: 10.1111/j.1600-0609.2010.01482.x